Parkinson's Disease Content Portal

PD Expertise

At IXICO, we are committed to transforming the landscape of Parkinson’s Disease research through advanced neuroimaging and biomarker analytics. Our AI-powered platform delivers precise and actionable insights to support the understanding, diagnosis, and treatment of PD.

Key Technology and Service Features
  • Precision in Neuroscience - Our platform delivers precision across medicine, imaging, insights, analytics, care, technology, data, results, and research—empowering breakthroughs in Parkinson’s Disease.
  • Advanced Technology The IXICO Platform is at the forefront of neuroimaging innovation, enhancing the evaluation of drug safety, patient eligibility, and therapeutic efficacy in Parkinson’s clinical trials.
  • End-to-End Solutions We provide comprehensive solutions—from scientific protocol definition to site setup, data acquisition, image reading, analysis, quality control, and secure data transfer—streamlining the research process.
  • Technology Excellence Our platform captures and quantifies PD-relevant biomarkers with high accuracy, paving the way for the next generation of regulatory-grade imaging biomarkers.
  • Scientific Excellence We translate cutting-edge neuroscience into validated, regulatorily compliant biomarkers that are essential for leadership and progress in Parkinson’s research.
  • Service Excellence We simplify the logistical and scientific complexities of neuroimaging, enabling our clients to focus on discovery, development, and clinical implementation in Parkinson’s Disease.

Insights on Imaging for Parkinson's Disease

     

A series of blogs showcasing our insight and thoughts in PD clinical research

PD Factsheet

IXICO excels in PD imaging with advanced biomarkers to quantify measures such as neuromelanin loss, substantia nigra degeneration, and brain structural changes. Our platform enhances the accuracy and efficiency of neuroimaging measurements, supporting an ever-growing volume of brain scans across global Parkinson’s research initiatives.

Case Study

IXICO supported a 6-year, multi-national clinical trial involving 250+ participants across 220+ sites, delivering precision neuroimaging to assess Parkinson’s Disease biomarkers.

Using advanced MRI and DaTScan techniques, IXICO provided:

  • Centralised imaging data management
  • Expert radiology reads with rapid turnaround
  • Regulatory-compliant workflows
  • Scientific oversight and consultancy

Outcome: All imaging endpoints met, enabling high-quality data for clinical and regulatory decisions. 

Download to read more


Cookie policy

We use cookies to understand more about who's visiting our website, and, where we can, to provide you with a more tailored service. You can change your cookie settings at any time.

Accept all cookies Manage cookie settings